Characterization of monoclonal gammopathy of undetermined significance by calorimetric analysis of blood serum proteome

PloS One
Francisca BarcelóJosé Portugal

Abstract

Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant proliferative disorder that may progress to multiple myeloma, a malignant plasma cell neoplasia. We evaluated differential scanning calorimetry (DSC) as an experimental tool for differentiating serum samples of MGUS patients from healthy individuals. DSC thermograms can be used for monitoring changes in the serum proteome associated with MGUS. MGUS patients showed great variability in serum thermogram characteristics, which depended on the IgG, IgA or IgM isotypes and/or the κ or λ light chains. Thermogram feature parameters distinguished patients with MGUS from healthy people. Serum samples, named as non-MGUS, were also collected from patients with subjacent immunological pathologies who were discarded of having MGUS through serum immunofixation. They were used to verify the sensitivity of DSC for discriminating MGUS from related blood dyscrasias. Only some DSC thermogram feature parameters differentiated, to a lesser extent, between MGUS and non-MGUS individuals. We contemplate DSC as a tool for early diagnosis and monitoring of MGUS.

References

Jun 3, 2004·Electrophoresis·Ming ZhouThomas P Conrads
May 14, 2005·Proceedings of the National Academy of Sciences of the United States of America·Gil MorDavid C Ward
Mar 31, 2006·The New England Journal of Medicine·Robert A KyleL Joseph Melton
Jun 30, 2006·The New England Journal of Medicine·Ruth Collins-Nakai
Aug 30, 2006·British Journal of Haematology·Robert A Kyle, S Vincent Rajkumar
Dec 29, 2006·The New England Journal of Medicine·Joan Bladé
Oct 24, 2007·Biophysical Journal·Nichola C GarbettJonathan B Chaires
Nov 3, 2007·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·N C GutiérrezJ F San Miguel
Nov 22, 2007·Clinical Chemistry·Nichola C GarbettJonathan B Chaires
Jan 17, 2009·Experimental and Molecular Pathology·Nichola C GarbettJonathan B Chaires
Jun 1, 2008·Proteomics. Clinical Applications·Judith Y M N EngwegenJos H Beijnen
Jan 26, 2011·Annual Review of Pathology·Kenneth C Anderson, Ruben D Carrasco
Aug 21, 2012·Biochimica Et Biophysica Acta·Svetla TodinovaStefka G Taneva
Jul 19, 2013·European Journal of Haematology·Silvia MangiacavalliAlessandro Corso
Dec 6, 2014·Analytical Chemistry·Svetla TodinovaStefka G Taneva

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis
Protein Assay

Software Mentioned

Sage
HUSE

Related Concepts

Related Feeds

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.